Recursion(RXRX) - 2025 Q4 - Annual Results

Exhibit 99.1 Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update SALT LAKE CITY, February 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq : RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its fourth quarter and full year ending December 31, 2025. Recursion will host an earnings Call on February 25, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT from Recursion's X ...